2,047 Shares in Axon Enterprise, Inc $AXON Bought by Thoroughbred Financial Services LLC

Thoroughbred Financial Services LLC acquired a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 2,047 shares of the biotechnology company’s stock, valued at approximately $1,469,000.

Several other institutional investors and hedge funds also recently modified their holdings of AXON. Vanguard Group Inc. grew its stake in shares of Axon Enterprise by 4.2% in the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock valued at $6,684,217,000 after buying an additional 376,904 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Axon Enterprise by 5.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,072,186 shares of the biotechnology company’s stock worth $1,713,332,000 after acquiring an additional 115,349 shares during the period. Jennison Associates LLC grew its position in Axon Enterprise by 53.8% in the third quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock valued at $677,412,000 after acquiring an additional 330,213 shares in the last quarter. Vestor Capital LLC raised its stake in shares of Axon Enterprise by 438,636.3% during the second quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company’s stock valued at $690,170,000 after purchasing an additional 833,409 shares during the period. Finally, Norges Bank purchased a new stake in shares of Axon Enterprise during the second quarter valued at approximately $637,806,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 1,797 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $539.23, for a total transaction of $968,996.31. Following the sale, the insider directly owned 83,485 shares in the company, valued at approximately $45,017,616.55. This represents a 2.11% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brittany Bagley sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $580.00, for a total value of $1,160,000.00. Following the completion of the sale, the chief financial officer directly owned 103,501 shares in the company, valued at approximately $60,030,580. This trade represents a 1.90% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 48,040 shares of company stock valued at $27,249,338. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Up 17.6%

Shares of NASDAQ:AXON opened at $520.18 on Thursday. The company’s fifty day moving average is $539.22 and its two-hundred day moving average is $628.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. Axon Enterprise, Inc has a 1-year low of $396.41 and a 1-year high of $885.91. The stock has a market capitalization of $41.05 billion, a price-to-earnings ratio of 342.23, a price-to-earnings-growth ratio of 13.33 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The business had revenue of $796.72 million during the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.94%. The company’s revenue for the quarter was up 38.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.08 EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on AXON shares. Robert W. Baird set a $800.00 price target on shares of Axon Enterprise in a research note on Wednesday. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, November 5th. Piper Sandler dropped their target price on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a research report on Wednesday. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Finally, Morgan Stanley lowered their price objective on Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating for the company in a research note on Wednesday. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $762.93.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and strong guidance — Axon reported Q4 revenue of ~$797M (+39% YoY) and non‑GAAP EPS $2.15, beating Street estimates; management issued FY26 growth guidance and a 2028 target of $6B in revenue, supporting upside expectations. PR Newswire: Axon reports Q4 2025
• Positive Sentiment: AI is accelerating demand — Management highlighted AI features across devices and software (body cams, evidence management, report drafting), which investors interpreted as boosting SaaS adoption and bookings momentum. Coverage noting the “AI supercharge” reaction: Investopedia: Axon AI story
• Positive Sentiment: Bookings/backlog and retention — Management disclosed a sizable increase in contracted bookings/backlog and a high net revenue retention (~125%), signaling both strong new sales and upsells from existing customers. This underpins longer‑term revenue visibility. MarketBeat: Q4 results & guidance deck
• Neutral Sentiment: Earnings call/transcript available — Investors can review management commentary and Q&A for nuance on federal spending, enterprise demand and AI rollout. Seeking Alpha: Q4 2025 transcript
• Neutral Sentiment: Short‑interest data flagged as anomalous — a February short‑interest entry shows 0 shares / NaN change (likely a reporting error); not meaningful for positioning until clarified.
• Negative Sentiment: Analysts trimmed price targets despite the beat — several firms cut PTs (UBS to $570/neutral; Barclays, Morgan Stanley, Piper reduced PTs but kept overweight views in many cases), which could cap upside and reflect lingering valuation/near‑term risk concerns. Benzinga: analyst PT cuts

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.